These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15552317)

  • 21. The effects of clopidogrel and omeprazole on platelet function in normal dogs.
    Thames BE; Lovvorn J; Papich MG; Wills R; Archer T; Mackin A; Thomason J
    J Vet Pharmacol Ther; 2017 Apr; 40(2):130-139. PubMed ID: 27452307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. W1, a Novel Oral Antiplatelet Agent With Less Resistance Than Clopidogrel.
    Ge P; Du L; Han C; Li H; Feng Y; Han J; Wang Z; Xiong L; Yuan M; Liu Y
    J Cardiovasc Pharmacol; 2017 Feb; 69(2):110-117. PubMed ID: 27930430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin.
    De Kam PJ; Luo WL; Wenning L; Ratcliffe L; Sisk CM; Royalty J; Radziszewski W; Wagner JA; Lai E
    Platelets; 2014; 25(7):480-7. PubMed ID: 24206527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
    Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and platelet aggregation inhibitory effects of a novel intravenous formulation of clopidogrel in humans.
    Cushing DJ; Souney PF; Cooper WD; Mosher GL; Adams MP; Machatha S; Zhang B; Kowey PR
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):3-8. PubMed ID: 21933229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
    Storey RF; Husted S; Harrington RA; Heptinstall S; Wilcox RG; Peters G; Wickens M; Emanuelsson H; Gurbel P; Grande P; Cannon CP
    J Am Coll Cardiol; 2007 Nov; 50(19):1852-6. PubMed ID: 17980251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients.
    David JL; Limet R
    Thromb Haemost; 1999 Nov; 82(5):1417-21. PubMed ID: 10595630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
    Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
    Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Not all statins interfere with clopidogrel during antiplatelet therapy.
    Mach F; Senouf D; Fontana P; Boehlen F; Reber G; Daali Y; de Moerloose P; Sigwart U
    Eur J Clin Invest; 2005 Aug; 35(8):476-81. PubMed ID: 16101667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study.
    Gurbel PA; Bliden KP; Zaman KA; Yoho JA; Hayes KM; Tantry US
    Circulation; 2005 Mar; 111(9):1153-9. PubMed ID: 15738352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of effects of two different formulations of clopidogrel bisulfate tablets on platelet aggregation and bleeding time in healthy Korean volunteers: A single-dose, randomized, open-label, 1-week, two-period, phase IV crossover study.
    Shim CY; Park S; Song JW; Lee SH; Kim JS; Chung N
    Clin Ther; 2010 Aug; 32(9):1664-73. PubMed ID: 20974324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
    Caplain H
    Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of different loading doses of clopidogrel on platelet aggregation].
    Liu QZ; Hong T; Liu ZP; Shi LB; Sheng QH; Gong YJ; Meng L; Jiang J; Huo Y
    Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):107-10. PubMed ID: 17445432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin.
    Husted S; Emanuelsson H; Heptinstall S; Sandset PM; Wickens M; Peters G
    Eur Heart J; 2006 May; 27(9):1038-47. PubMed ID: 16476694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term activity of clopidogrel: a three-month appraisal in healthy volunteers.
    Caplain H; Cariou R
    Semin Thromb Hemost; 1999; 25 Suppl 2():21-4. PubMed ID: 10440418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-centre, randomised study on platelet reactivity after abrupt or gradual discontinuation of long-term clopidogrel therapy in patients after percutaneous coronary intervention.
    Nadrowski P; Syzdół M; Wańha W; Nabiałek E; Skrzypek M; Góral J; Siewniak M; Kozakiewicz K; Ochała A; Tendera M; Wojakowski W
    Kardiol Pol; 2016; 74(7):634-43. PubMed ID: 26779855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.
    Matetzky S; Fefer P; Shenkman B; Varon D; Savion N; Hod H
    Am J Cardiol; 2008 Sep; 102(5):524-9. PubMed ID: 18721506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.